Santi, M.D.; Zhang, M.; Liu, N.; Viet, C.T.; Xie, T.; Jensen, D.D.; Amit, M.; Pan, H.; Ye, Y.
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance. Pharmaceuticals 2023, 16, 1558.
https://doi.org/10.3390/ph16111558
AMA Style
Santi MD, Zhang M, Liu N, Viet CT, Xie T, Jensen DD, Amit M, Pan H, Ye Y.
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance. Pharmaceuticals. 2023; 16(11):1558.
https://doi.org/10.3390/ph16111558
Chicago/Turabian Style
Santi, Maria Daniela, Morgan Zhang, Naijiang Liu, Chi T. Viet, Tongxin Xie, Dane D. Jensen, Moran Amit, Huilin Pan, and Yi Ye.
2023. "Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance" Pharmaceuticals 16, no. 11: 1558.
https://doi.org/10.3390/ph16111558
APA Style
Santi, M. D., Zhang, M., Liu, N., Viet, C. T., Xie, T., Jensen, D. D., Amit, M., Pan, H., & Ye, Y.
(2023). Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance. Pharmaceuticals, 16(11), 1558.
https://doi.org/10.3390/ph16111558